ANTINEOPLASTIC AGENTS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
Public routes to check: ODB 65 and over. Listing alone does not establish eligibility or payment.
47 ingredients · 365 matching product records. Ontario extract of September 22, 2026.
| Ingredient / brands | Strengths and forms | Ontario listings | Browse |
|---|---|---|---|
| ABIRATERONE ACETATEZytiga, Reddy-Abiraterone, Sandoz Abiraterone and 7 more brands | 250 mg Tab; 500 mg Tab | General benefit | View 18 products |
| AFATINIBGiotrif, Sandoz AFAtinib, Mar-Afatinib | 20 mg Tab; 30 mg Tab; 40 mg Tab | Off-Formulary Interchangeable, not an ODB benefit | View 9 products |
| ALTRETAMINEHexalen | 50 mg Cap | General benefit | View 1 product |
| ANASTROZOLEArimidex, PMS-Anastrozole, Ran-Anastrozole and 13 more brands | 1 mg Tab | General benefit | View 18 products |
| BICALUTAMIDECasodex, Teva-Bicalutamide, Co Bicalutamide and 6 more brands | 50 mg Tab | Listed, not a benefit; General benefitVaries by product. Open the list to check. | View 9 products |
| BOSUTINIBBosulif, Reddy-Bosutinib | 100 mg Tab; 500 mg Tab | Off-Formulary Interchangeable, not an ODB benefit | View 4 products |
| BUSERELIN ACETATESuprefact Depot 2 Months, Suprefact Depot 3 Months, Suprefact | 6.3 mg Implant Kit; 9.45 mg Implant Kit; 1 mg/mL Inj Sol-5.5mL Pk; 1 mg/mL Nas Sp-10mL Pk | General benefit | View 4 products |
| BUSULFANMyleran | 2 mg Tab | General benefit | View 1 product |
| CAPECITABINEXeloda, Teva-Capecitabine, Sandoz Capecitabine and 4 more brands | 150 mg Tab; 500 mg Tab | General benefit | View 15 products |
| CHLORAMBUCILLeukeran | 2 mg Tab | General benefit | View 1 product |
| CYCLOPHOSPHAMIDEProcytox, Cytoxan | 25 mg Tab; 50 mg Tab | General benefit; Listed, not a benefitVaries by product. Open the list to check. | View 3 products |
| CYPROTERONE ACETATEAndrocur, Cyproterone, Med-Cyproterone and 1 more brand | 50 mg Tab | General benefit | View 4 products |
| DASATINIBSprycel, Apo-Dasatinib, Teva-Dasatinib and 3 more brands | 20 mg Tab; 50 mg Tab; 70 mg Tab; 80 mg Tab 2 more forms in product list | Off-Formulary Interchangeable, not an ODB benefit | View 33 products |
| DAUNORUBICINCerubidine | Inj Pd-20mg Pk | General benefit | View 1 product |
| DEGARELIX ACETATEFirmagon | 80 mg Pd for Inj-Vial Pk; 120 mg Pd for Inj-Vial Pk | General benefit | View 2 products |
| ENZALUTAMIDEXtandi, Auro-Enzalutamide, Jamp Enzalutamide and 2 more brands | 40 mg Cap | Off-Formulary Interchangeable, not an ODB benefit | View 5 products |
| ERLOTINIBTarceva, Teva-Erlotinib, Apo-Erlotinib and 2 more brands | 25 mg Tab; 100 mg Tab; 150 mg Tab | Off-Formulary Interchangeable, not an ODB benefit | View 14 products |
| ETOPOSIDEVepesid | 50 mg Cap | General benefit | View 1 product |
| EVEROLIMUSAfinitor, Teva-Everolimus, Sandoz Everolimus and 3 more brands | 2.5 mg Tab; 5 mg Tab; 10 mg Tab | Off-Formulary Interchangeable, not an ODB benefit | View 18 products |
| EXEMESTANEAromasin, Act Exemestane, Med-Exemestane | 25 mg Tab | General benefit | View 3 products |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-09-22.xml, extract 2026-09-22. Ontario class index: formulary-ed43-front-matter.txt, Part V.
10:00 ANTINEOPLASTIC AGENTS.